Wall Street analysts expect that NutriSystem Inc. (NASDAQ:NTRI) will post sales of $163.87 million for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for NutriSystem’s earnings, with estimates ranging from $162.90 million to $164.50 million. NutriSystem reported sales of $158.15 million in the same quarter last year, which indicates a positive year over year growth rate of 3.6%. The business is expected to report its next earnings results on Wednesday, October 24th.

On average, analysts expect that NutriSystem will report full-year sales of $701.07 million for the current year, with estimates ranging from $700.50 million to $702.20 million. For the next financial year, analysts anticipate that the business will report sales of $766.80 million, with estimates ranging from $759.20 million to $772.60 million. Zacks’ sales averages are a mean average based on a survey of sell-side analysts that cover NutriSystem.

NutriSystem (NASDAQ:NTRI) last released its quarterly earnings data on Monday, July 30th. The company reported $0.87 EPS for the quarter, beating analysts’ consensus estimates of $0.81 by $0.06. NutriSystem had a return on equity of 43.29% and a net margin of 7.94%. The business had revenue of $191.30 million for the quarter, compared to the consensus estimate of $189.07 million. During the same quarter in the prior year, the business posted $0.80 EPS. The business’s revenue for the quarter was down 1.8% on a year-over-year basis.

A number of research analysts have recently commented on the company. Zacks Investment Research upgraded NutriSystem from a “hold” rating to a “buy” rating and set a $43.00 price objective on the stock in a report on Thursday, June 21st. BidaskClub upgraded NutriSystem from a “sell” rating to a “hold” rating in a research note on Thursday, June 21st. Barrington Research restated a “hold” rating on shares of NutriSystem in a research note on Wednesday, August 1st. ValuEngine upgraded NutriSystem from a “strong sell” rating to a “sell” rating in a research note on Friday. Finally, B. Riley raised their price target on NutriSystem from $52.00 to $53.00 and gave the stock a “buy” rating in a research note on Tuesday, July 31st. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $46.50.

A number of large investors have recently added to or reduced their stakes in the stock. US Bancorp DE grew its stake in NutriSystem by 64.7% during the 2nd quarter. US Bancorp DE now owns 3,726 shares of the company’s stock worth $143,000 after buying an additional 1,464 shares during the last quarter. Principal Financial Group Inc. lifted its position in NutriSystem by 0.8% during the 1st quarter. Principal Financial Group Inc. now owns 250,443 shares of the company’s stock worth $6,749,000 after acquiring an additional 2,095 shares during the period. Legal & General Group Plc lifted its position in NutriSystem by 3.9% during the 2nd quarter. Legal & General Group Plc now owns 63,544 shares of the company’s stock worth $2,434,000 after acquiring an additional 2,378 shares during the period. Swiss National Bank lifted its position in NutriSystem by 4.8% during the 1st quarter. Swiss National Bank now owns 52,400 shares of the company’s stock worth $1,412,000 after acquiring an additional 2,400 shares during the period. Finally, Lapides Asset Management LLC lifted its position in NutriSystem by 2.2% during the 2nd quarter. Lapides Asset Management LLC now owns 120,500 shares of the company’s stock worth $4,639,000 after acquiring an additional 2,600 shares during the period.

NTRI opened at $37.10 on Friday. NutriSystem has a one year low of $26.06 and a one year high of $60.80. The stock has a market capitalization of $1.09 billion, a PE ratio of 18.93, a price-to-earnings-growth ratio of 1.78 and a beta of 1.27.

NutriSystem Company Profile

Nutrisystem, Inc, together with its subsidiaries, provides weight management products and services for women and men in the United States. The company offers weight loss programs that consist primarily of a pre-packaged food program, digital tools, and counseling. It also provides Nutrisystem Lean13 program, which provides weight loss, and support and counseling services; the South Beach Diet, a weight-loss program; and Nutrisystem 5-day kit, a ?D' kit that offers individuals with or at risk of type 2 diabetes.

Recommended Story: Google Finance

Get a free copy of the Zacks research report on NutriSystem (NTRI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for NutriSystem (NASDAQ:NTRI)

Receive News & Ratings for NutriSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NutriSystem and related companies with MarketBeat.com's FREE daily email newsletter.